Stock Events

Stock Events

Telomir Pharmaceuticals (TELO) Q4 2024 Earnings

Nov 12Confirmed

Q4 2024

-0.2

0.13

0.47

0.8

Details

Expected EPS

-0.2

Actual EPS

-0.2

Surprise EPS

0

Surprise Percent

+0%

Description

⁨Telomir Pharmaceuticals⁩ (⁦TELO⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.